Opko Health (OPK) Restructuring Costs (2012 - 2013)
Opko Health's (OPK) quarterly Restructuring Costs came in at $2.6 million in Q2 2013, up 167.05% YoY from $965000.0 in Q2 2012, and up 91.74% on a QoQ basis from $1.3 million in Q1 2013.
Opko Health (OPK) Restructuring Costs (2012 - 2013) Analysis & Trends
Opko Health (OPK) has 2 years of Restructuring Costs data on file, last reported at $2.6 million in Q2 2013.
- Quarterly Restructuring Costs rose 167.05% year-over-year to $2.6 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $2.6 million (changed N/A YoY) and the FY2012 annual result came in at $785000.0, changed N/A from the prior year.
- Restructuring Costs rose to $2.6 million in Q2 2013, from $1.3 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q2 2013 to a low of -$1.9 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Opko Health | 993.18 Mn | 692.42 Mn | 80.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 2.58 Mn |
| Mar 31, 2013 | 1.34 Mn |
| Dec 31, 2012 | -1.88 Mn |
| Sep 30, 2012 | 556,000.00 |
| Jun 30, 2012 | 965,000.00 |
| Mar 31, 2012 | 1.14 Mn |